Treatment Assessment of pNET and NELM after Everolimus by Quantitative MRI Parameters

Assessment of treatment response to targeted therapies such as everolimus is difficult, especially in slow-growing tumors such as NETs. In this retrospective study, 17 patients with pancreatic neuroendocrine tumors (pNETs) and hepatic metastases (NELMs) (42 target lesions) who received everolimus we...

Descripción completa

Detalles Bibliográficos
Autores principales: Ingenerf, Maria, Kiesl, Sophia, Winkelmann, Michael, Auernhammer, Christoph J., Rübenthaler, Johannes, Grawe, Freba, Fabritius, Matthias P., Ricke, Jens, Schmid-Tannwald, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599819/
https://www.ncbi.nlm.nih.gov/pubmed/36289880
http://dx.doi.org/10.3390/biomedicines10102618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599819/
https://www.ncbi.nlm.nih.gov/pubmed/36289880
http://dx.doi.org/10.3390/biomedicines10102618

Ejemplares similares